Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Zentalis Pharmaceuticals
ZNTL
$332M
| $2.25M | ﹤0.01% |
33,834
-42,731
| -56% | -$2.47M |
|
|
CHCT
2427
Community Healthcare Trust
CHCT
$527M
| $2.25M | ﹤0.01% |
49,837
-6,959
| -12% | -$337K |
|
|
HUYA
2428
Huya Inc
HUYA
$579M
| $2.25M | ﹤0.01% |
270,020
+25,808
| +11% | +$298K |
|
2429
First Trust New York Municipal High Income ETF
FMNY
$38.1M
| $2.25M | ﹤0.01% |
75,000
-25,000
| -25% | -$759K |
|
2430
Seres Therapeutics
MCRB
$48.3M
| $2.25M | ﹤0.01% |
16,146
+6,003
| +59% | +$1.17M |
|
|
GTY
2431
Getty Realty Corp
GTY
$2.12B
| $2.24M | ﹤0.01% |
76,471
+3,357
| +5% | +$105K |
|
2432
Opko Health
OPK
$985M
| $2.24M | ﹤0.01% |
613,490
-555,806
| -48% | -$2.07M |
|
2433
Pegasystems
PEGA
$5.19B
| $2.24M | ﹤0.01% |
35,232
-74,644
| -68% | -$4.97M |
|
2434
SiteOne Landscape Supply
SITE
$4.25B
| $2.23M | ﹤0.01% |
11,186
-9,680
| -46% | -$1.83M |
|
|
RBCP
2435
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $2.23M | ﹤0.01% |
+20,000
| New | +$2.32M |
|
2436
RB Global
RBA
$20.9B
| $2.23M | ﹤0.01% |
36,119
-71,933
| -67% | -$4.39M |
|
2437
CALL
Vale
VALE
$62.1B
| $2.22M | ﹤0.01% |
159,400
+79,400
| +99% | +$1.56M |
|
|
DHCAU
2438
DELISTED
DHC Acquisition Corp. Unit
DHCAU
| $2.22M | ﹤0.01% |
223,900
| – | – |
|
|
LOGC
2439
DELISTED
ContextLogic
LOGC
| $2.22M | ﹤0.01% |
13,535
+9,536
| +238% | +$2.37M |
|
|
HI
2440
DELISTED
Hillenbrand
HI
| $2.21M | ﹤0.01% |
51,872
-16,425
| -24% | -$721K |
|
2441
Houlihan Lokey
HLI
$8.69B
| $2.21M | ﹤0.01% |
23,990
+6,639
| +38% | +$582K |
|
|
CMO
2442
DELISTED
Capstead Mortgage Corp.
CMO
| $2.21M | ﹤0.01% |
330,199
+157,885
| +92% | +$1.03M |
|
2443
CALL
Vroom Inc
VRM
$37M
| $2.21M | ﹤0.01% |
+1,250
| New | +$3.18M |
|
|
AZUL
2444
DELISTED
Azul
AZUL
| $2.21M | ﹤0.01% |
109,951
+9,889
| +10% | +$217K |
|
2445
Alector
ALEC
$163M
| $2.2M | ﹤0.01% |
96,507
-54,737
| -36% | -$1.53M |
|
2446
Selective Insurance
SIGI
$5.67B
| $2.2M | ﹤0.01% |
29,118
+22,929
| +370% | +$1.85M |
|
2447
iShares MSCI USA Quality Factor ETF
QUAL
$46.9B
| $2.2M | ﹤0.01% |
16,683
-2,689
| -14% | -$370K |
|
2448
iShares Morningstar Growth ETF
ILCG
$3.12B
| $2.2M | ﹤0.01% |
33,494
-24,332
| -42% | -$1.64M |
|
2449
Valmont Industries
VMI
$9.34B
| $2.2M | ﹤0.01% |
9,338
-7,763
| -45% | -$1.85M |
|
2450
Schwab US Dividend Equity ETF
SCHD
$104B
| $2.19M | ﹤0.01% |
88,713
-92,202
| -51% | -$2.34M |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.